The store will not work correctly when cookies are disabled.
2-(2-(1H-1,2,4-triazol-1-yl)-5-(trifluoromethoxy)phenyl)-5-(2-methoxypyridin-4-yl)-1,3,4-oxadiazole
ID: ALA4567091
PubChem CID: 155543925
Max Phase: Preclinical
Molecular Formula: C17H11F3N6O3
Molecular Weight: 404.31
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cc(-c2nnc(-c3cc(OC(F)(F)F)ccc3-n3cncn3)o2)ccn1
Standard InChI: InChI=1S/C17H11F3N6O3/c1-27-14-6-10(4-5-22-14)15-24-25-16(28-15)12-7-11(29-17(18,19)20)2-3-13(12)26-9-21-8-23-26/h2-9H,1H3
Standard InChI Key: QVGARJDDCADCNR-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
23.7785 -20.2227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6541 -18.9935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6530 -19.8130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3611 -20.2220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0707 -19.8125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0679 -18.9899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3593 -18.5846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.3568 -17.7674 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.0633 -17.3567 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0609 -16.5395 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
23.7722 -17.7632 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
23.7687 -16.9423 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
22.3609 -21.0392 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.7010 -21.5220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9533 -22.2993 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.7705 -22.2995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0231 -21.5223 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.8623 -21.0392 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.6622 -21.2105 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.0723 -20.5026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5258 -19.8940 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.8860 -20.4999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2933 -21.2055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.1062 -21.2032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2864 -19.7969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.0949 -19.7916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.5064 -20.4951 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.4991 -19.0814 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.3163 -19.0764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 2 1 0
7 8 1 0
8 9 1 0
9 10 1 0
9 11 1 0
9 12 1 0
5 1 1 0
4 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 13 1 0
1 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 1 1 0
20 22 1 0
22 23 2 0
23 24 1 0
24 27 2 0
26 25 2 0
25 22 1 0
26 27 1 0
26 28 1 0
28 29 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 404.31 | Molecular Weight (Monoisotopic): 404.0845 | AlogP: 3.29 | #Rotatable Bonds: 5 |
Polar Surface Area: 100.98 | Molecular Species: NEUTRAL | HBA: 9 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 9 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 1.57 | CX LogP: 3.05 | CX LogD: 3.05 |
Aromatic Rings: 4 | Heavy Atoms: 29 | QED Weighted: 0.50 | Np Likeness Score: -1.73 |
References
1. Reed CW, Washecheck JP, Quitlag MC, Jenkins MT, Rodriguez AL, Engers DW, Blobaum AL, Conn PJ, Niswender CM, Lindsley CW.. (2019) Surveying heterocycles as amide bioisosteres within a series of mGlu7 NAMs: Discovery of VU6019278., 29 (10): [PMID:30910459] [10.1016/j.bmcl.2019.03.016] |